Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration

Post time 2025-9-12 08:35:28

journal：Ophthalmology Retina

Authors：Jan Hamouz; Agnieszka Nowosielska; Anna wich-Zubilewicz; Santiago Abengoechea; Kristine Baumane; Attila Vajas; Magorzata Siewierska; Milan Veselovsky; Miroslav Veith; gnes Kerényi; Shobhana Mange; Krishnapada Baidya; Guna Laganovska; Ignasi Jürgens; András Papp; Jignesh Gosai; Jana tefanickova; Mei Han; Piotr Fryczkowski; Dominik Zalewski; Jing Wang; Wenbin Wei

Published date：2025-4-

DOI：10.1016/j.oret.2024.10.001

PDF link：https://www.sciencedirect.com/sc ... 468653024004718/pdf

Article link：https://doi.org/10.1016/j.oret.2024.10.001

Article Source：Elsevier BV。

Remark：

Post time 2025-9-12 08:35:29

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration Copy